SWF file not found. Please check the path.
سایر همایشهای انگليسي-مطالعات پايه در مورد HTLV (ويرولوژي،ايمونولوژي، ژنتيك و ...)
مرتب سازی بر اساس عنوان مطلب
مرتب سازی بر اساس تاریخ ایجاد
Unpublished
Title Filter
Display #
5
10
15
20
25
30
50
100
All
A comparison on HTLV-I proviral load and clinical features of HAM/TSP among Iranian and Japanese (A-10-1484-1)
An Evaluation on HTLV-I Activity in HAM/TSP Patients before and after Triple Therapy (B-76)
Assessment the Activity of HTLV-1 in HAM/TSP Patients Using Tax mRNA Expression and Proviral Load After in Vitro Lymphocyte Activation
Assessment the Activity of HTLV-1 in HAM/TSP Patients Using Tax mRNA Expression and Proviral Load After in Vitro Lymphocyte Activation (P-179)
Association between novel human perforin gene polymorphism and HTLV-I-associated/myelopathy tropical spastic paraparesis -HAM/TSP
Bioinformatics analysis and structural alignment of HTLV-1 integrase protein (PV-43)
Comparison of IL-12, IL-18 and IFN-γ Gene Expression in HTLV-1-Associated Myelopathy ⁄ Tropical Spastic Paraparesis (HAM/TSP) Patients, HTLV-1 Carriers and HTLV-1 Negative Individuals
Cytokine gene polymorphism in HTLV-I-associated myelopathy tropical spastic paraparesis-HAM/TSP
Cytotoxic and inflammatory markers determined the outcome of HTLV-1 infection
Description of a virological marker in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I Associated Myelopathy (HAM-TSP) and Healthy Carriers (A-10-1327-1)
Effects of melphalan on the expr ession of NF-κB in human lymphoma cells
Effects of sesquiterpene lactone parthenolide on the expr ession of NF-κB in human lymphoma cells
Effects of Umbelliprenin on the expression of NF-κB in human leukemia/lymphoma cells
Evaluation for INOS gene expression a study in adult T cell leukemia malignancy associated with HTLV-1 (PV-26)
Evaluation of activity markers of regulatory T cells and proviral load in HTLV-I-associated myelopathy/tropical spastic paraparesis patient activity
Evaluation of Gene and Protein Levels of IL-33 and Soluble Receptor (ST2-Receptor) Patients with HAM/TSP and HTLV-1 Carriers
Evaluation of HTLV-I and host interaction on development of adult T cell leukemia/lymphoma: study of HBZ, RORγt, FOXP3 genes expression
Evaluation of IL-2 receptor among HAM /TSP Patients and HTLV-I Carriers in Mashhad,Iran
Evaluation of immune markers profile of HTLV-1 infected people in northeast of Iran
Evaluation of interleukin-1 beta (IL-1β), before and after curcumin treatment in HAM/TSP patients and HTLV-1 carriers
Evaluation of LAT and c-Fos expression in Adult T cell Lukemia/lymphoma and healthy carriers (A-10-1336-1)
Evaluation of TAX and BCL-XL gene expression in Adult T cell Leukemia/Lymphoma (ATL) and Healthy Carriers (A-10-1327-2)
Expression Of IL-2Ra Chain (CD25) On Peripheral Blood LymphocyteOf HAM/TSP Patients
Genetic analyses of HTLV-I from India and newly identified endemic Loci, Iranian Mashhad and Russia
High Level Soluble Expression and One-step Purification of HTLV-I p19 Protein in Escherichia coli by Fusion Expression (A-10-277-1)
HLA CLASS II-LINKED GENE CONTROLS SUSCEPTIBILITY TO HTLV-1 INFECTION IN IRANIAN JEWS IN ISRAEL
HLA DRb genes contribute to susceptibility and resistance to HAM/TSP
HTLV-1 in Kuwait: Close sequence homology with HTLV-1 originating in Mashhad region of Iran
HTLV-1 infected asymptomatic carriers overexpress the cell-mediated cytotoxicity genes
HTLV-1 Infection Dampens NK cell Function
HTLV-I and associated diseases: groups at risk in Europe
HTLV-I and host interaction on development of HTLV-associated myelopathy-tropical spastic paraparesis (HAM/TSP): study of HBZ, AKT1, BAD, IFN-λ3 genes expression (PV-23)
IFN-a2b reduces released particles of HTLV-I from HTLV-I transformed cell line
Increased of PDGF-β gene expression is associated with ATLL development in HTLV-1 carriers
Interaction of Perforin and Grnazyme Band HTLV-1 Viral factors Is Associated with ATLL development
Melphalan cytotoxicity increased in combination with Arsenic trioxode in MT-2 lymphoma cells
Molecular characterization of HTLV-I infection in Israel
Neurofilament Light Chain: A Possible Biomarker to Predict Development of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (P-293)
Parthenolide cytotoxicity increased in combination with Arsenic trioxode in MT2 lymphoma cells
Purification and Seroprevalence of K55 Peptide Specific Antibodies among HTLV-ll Infected Serum in Mashhad Population (PB-060)
Role of microRNAs in HTLV-1 infection
Sequence and Phylogenetic Analysis of LTR region of Human T-Cell Lymphotropic Virus Type 1 from Mashhad, Iran
Sequencing of HTLV1 p12 region in HAM/TSP, ATL patients and HTLV1 carriers in Mashhad, Iran
Serum Total Antioxidant Capacity Status of HTLV-1 Infected Patients (A-10-1267-1)
Study of the Effects of Combined Therapy with Sodium Valproate, Peg-interferon and Corticosteroid on Proviral Load of HTLV-1 and Expression of Rel-A, Creb and IL-1 Genes in Patients with HTLV-1 Associated Spastic Paraparesis (HAM/TSP)
The Association between Serum Calcium and Vitamin D, HTLV-1 Proviral Load, and the Severity of HAM/ TSP Clinical Symptoms (P-41)
The Effect of HTLV-1 Virulence Factors (HBZ, Tax, Proviral Load), and Expression of CXCR3 and CCR6 and Their Ligands on Manifestation of HTLV-1 Associated Myelopathy Tropical Spastic Paraparesis (P-149)
The Effects of Curcumin on Apoptosis and Cytotoxicity-Related Molecules in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients
The effects of curcumin on gene expression and serum levels of Toll like receptor -2 &4 (TLR-2 and TLR-4) in patients with myelopathy associated with HTLV-1 (HAM/TSP) and virus carriers
The evaluation of FOXP3 and GITR gene expression in ATL patients before and after treatment with triple arsenic regimen using real time PCR TaqMan method
The impact of HTLV-I/HIV co-infection on HTLV-I proviral and HIV viral load (AA-10-1484-2)
The role of Th1 and Th2 cytokines in immune response to HTLV-1 associated myelopathy/tropical spastic paraparesis
Umbelliprenin cytotoxicity increased in combination with arsenic trioxode in MT-2 leukemia/lymphoma cells
Viral and host genetic factors that determine the development of Ham/Tsp
Zidovudine and Interferon-α Treatment Reduces Vascular Endothelium Growth Factor in Patients with Adult T- Cell Leukemia